These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17948194

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Molecular magnetic resonance imaging of atrial clots in a swine model.
    Spuentrup E, Fausten B, Kinzel S, Wiethoff AJ, Botnar RM, Graham PB, Haller S, Katoh M, Parsons EC, Manning WJ, Busch T, Günther RW, Buecker A.
    Circulation; 2005 Jul 19; 112(3):396-9. PubMed ID: 16009790
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.
    Spuentrup E, Buecker A, Katoh M, Wiethoff AJ, Parsons EC, Botnar RM, Weisskoff RM, Graham PB, Manning WJ, Günther RW.
    Circulation; 2005 Mar 22; 111(11):1377-82. PubMed ID: 15738354
    [Abstract] [Full Text] [Related]

  • 7. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
    Vymazal J, Spuentrup E, Cardenas-Molina G, Wiethoff AJ, Hartmann MG, Caravan P, Parsons EC.
    Invest Radiol; 2009 Nov 22; 44(11):697-704. PubMed ID: 19809344
    [Abstract] [Full Text] [Related]

  • 8. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study.
    Katoh M, Haage P, Wiethoff AJ, Günther RW, Bücker A, Tacke J, Spuentrup E.
    Invest Radiol; 2009 Mar 22; 44(3):146-50. PubMed ID: 19151606
    [Abstract] [Full Text] [Related]

  • 9. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
    Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, Toussaint JF, Fayad ZA.
    Circulation; 2005 Sep 13; 112(11):1594-600. PubMed ID: 16145001
    [Abstract] [Full Text] [Related]

  • 10. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
    Spuentrup E, Ruhl KM, Botnar RM, Wiethoff AJ, Buhl A, Jacques V, Greenfield MT, Krombach GA, Günther RW, Vangel MG, Caravan P.
    Circulation; 2009 Apr 07; 119(13):1768-75. PubMed ID: 19307474
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C, Anelli PL, Lorusso V, Morisetti A, Maggioni F, Zheng J, Uggeri F, Cavagna FM.
    Invest Radiol; 2006 Mar 07; 41(3):279-91. PubMed ID: 16481911
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K, Breuckmann F, Hunold P, Barkhausen J, Schlosser T.
    Acta Radiol; 2009 May 07; 50(4):406-11. PubMed ID: 19308763
    [Abstract] [Full Text] [Related]

  • 15. High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent.
    Spuentrup E, Wiethoff AJ, Parsons EC, Spangenberg P, Stracke CP.
    Eur J Radiol; 2010 Jun 07; 74(3):445-52. PubMed ID: 19394183
    [Abstract] [Full Text] [Related]

  • 16. [MR imaging of lymph nodes using Gadofluorine M: feasibility in a swine model at 1.5 and 3T].
    Spuentrup E, Ruhl K, Weigl S, Misselwitz B, Wardeh D, Buhl A, Botnar RM, Katoh M, Wiethoff AJ, Günther RW.
    Rofo; 2010 Aug 07; 182(8):698-705. PubMed ID: 20419610
    [Abstract] [Full Text] [Related]

  • 17. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.
    Overoye-Chan K, Koerner S, Looby RJ, Kolodziej AF, Zech SG, Deng Q, Chasse JM, McMurry TJ, Caravan P.
    J Am Chem Soc; 2008 May 07; 130(18):6025-39. PubMed ID: 18393503
    [Abstract] [Full Text] [Related]

  • 18. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr 07; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 19. Determination of optimal gadolinium concentration using SSFP for catheter-directed contrast-enhanced coronary MR angiography.
    Schirf BE, Green JD, Sato K, Larson AC, Shaibani A, Salem R, Li D, Omary RA.
    Acad Radiol; 2005 Jun 07; 12(6):771-5. PubMed ID: 15935975
    [Abstract] [Full Text] [Related]

  • 20. Comparison study of intraarticular and intravenous gadolinium-enhanced magnetic resonance imaging of cartilage in a canine model.
    Kwack KS, Cho JH, Kim M MS, Yoon CS, Yoon YS, Choi JW, Kwon JW, Min BH, Sun JS, Kim SY.
    Acta Radiol; 2008 Feb 07; 49(1):65-74. PubMed ID: 17963083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.